{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T21:52:15Z","timestamp":1775166735387,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.biopsych.2013.09.019","type":"journal-article","created":{"date-parts":[[2013,9,30]],"date-time":"2013-09-30T15:57:03Z","timestamp":1380556623000},"page":"160-167","source":"Crossref","is-referenced-by-count":37,"title":["Elevated Viral Restriction Factor Levels in Cortical Blood Vessels in Schizophrenia"],"prefix":"10.1016","volume":"76","author":[{"given":"Benjamin I.","family":"Siegel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J.","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica R.","family":"Edelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Volk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2013.09.019_bib1","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature08185","article-title":"Common polygenic variation contributes to risk of schizophrenia and bipolar disorder","volume":"460","author":"Purcell","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2013.09.019_bib2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nature08192","article-title":"Common variants on chromosome 6p22.1 are associated with schizophrenia","volume":"460","author":"Shi","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2013.09.019_bib3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature08186","article-title":"Common variants conferring risk of schizophrenia","volume":"460","author":"Stefansson","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2013.09.019_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.schres.2010.07.001","article-title":"Common variants conferring risk of schizophrenia: A pathway analysis of GWAS data","volume":"122","author":"Jia","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2013.09.019_bib5","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/ng.940","article-title":"Genome-wide association study identifies five new schizophrenia loci","volume":"43","author":"Ripke","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2013.09.019_bib6","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archpsyc.61.8.774","article-title":"Serologic evidence of prenatal influenza in the etiology of schizophrenia","volume":"61","author":"Brown","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2013.09.019_bib7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1176\/appi.ajp.162.4.767","article-title":"Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring","volume":"162","author":"Brown","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2013.09.019_bib8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1176\/appi.ajp.161.5.889","article-title":"Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring","volume":"161","author":"Brown","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2013.09.019_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/appi.ajp.2009.09030361","article-title":"Prenatal infection and schizophrenia: A review of epidemiologic and translational studies","volume":"167","author":"Brown","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2013.09.019_bib10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.09.019_bib11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.09.019_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbi.2012.06.010","article-title":"Serum and gene expression profile of cytokines in first-episode psychosis","volume":"31","author":"Di Nicola","year":"2013","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.biopsych.2013.09.019_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/mp.2012.110","article-title":"Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia","volume":"18","author":"Fillman","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.09.019_bib14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.biopsych.2006.12.021","article-title":"Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia","volume":"62","author":"Arion","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.09.019_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-244X-7-46","article-title":"Inflammation-related genes up-regulated in schizophrenia brains","volume":"7","author":"Saetre","year":"2007","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.biopsych.2013.09.019_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri3344","article-title":"The broad-spectrum antiviral functions of IFIT and IFITM proteins","volume":"13","author":"Diamond","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.biopsych.2013.09.019_bib17","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","article-title":"The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus","volume":"139","author":"Brass","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2013.09.019_bib18","doi-asserted-by":"crossref","first-page":"e1002337","DOI":"10.1371\/journal.ppat.1002337","article-title":"IFITM3 inhibits influenza A virus infection by preventing cytosolic entry","volume":"7","author":"Feeley","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.biopsych.2013.09.019_bib19","doi-asserted-by":"crossref","first-page":"e1001258","DOI":"10.1371\/journal.ppat.1001258","article-title":"Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus","volume":"7","author":"Huang","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.biopsych.2013.09.019_bib20","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1128\/JVI.01531-10","article-title":"The IFITM proteins inhibit HIV-1 infection","volume":"85","author":"Lu","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.biopsych.2013.09.019_bib21","doi-asserted-by":"crossref","first-page":"e34508","DOI":"10.1371\/journal.pone.0034508","article-title":"IFITM proteins restrict antibody-dependent enhancement of dengue virus infection","volume":"7","author":"Chan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2013.09.019_bib22","doi-asserted-by":"crossref","first-page":"e1003124","DOI":"10.1371\/journal.ppat.1003124","article-title":"IFITM proteins restrict viral membrane hemifusion","volume":"9","author":"Li","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.biopsych.2013.09.019_bib23","doi-asserted-by":"crossref","first-page":"e1002909","DOI":"10.1371\/journal.ppat.1002909","article-title":"Ifitm3 limits the severity of acute influenza in mice","volume":"8","author":"Bailey","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.biopsych.2013.09.019_bib24","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/npp.2013.38","article-title":"Deficiency of schnurri-2, an MHC enhancer binding protein, induces mild chronic inflammation in the brain and confers molecular, neuronal, and behavioral phenotypes related to schizophrenia","volume":"38","author":"Takao","year":"2013","journal-title":"Neuropsychopharm"},{"key":"10.1016\/j.biopsych.2013.09.019_bib25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archpsyc.1995.03950160008002","article-title":"Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics","volume":"52","author":"Akbarian","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2013.09.019_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archpsyc.57.3.237","article-title":"Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia","volume":"57","author":"Volk","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2013.09.019_bib27","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archpsyc.57.11.1061","article-title":"Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder","volume":"57","author":"Guidotti","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2013.09.019_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0920-9964(01)00377-2","article-title":"Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: A preliminary study","volume":"58","author":"Vawter","year":"2002","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2013.09.019_bib29","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1523\/JNEUROSCI.23-15-06315.2003","article-title":"Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia","volume":"23","author":"Hashimoto","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2013.09.019_bib30","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/sj.mp.4001988","article-title":"Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression","volume":"12","author":"Straub","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.09.019_bib31","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.biopsych.2008.11.019","article-title":"Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia","volume":"65","author":"Mellios","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.09.019_bib32","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/cercor\/bhq169","article-title":"Lamina-specific alterations in cortical GABAA receptor subunit expression in schizophrenia","volume":"21","author":"Beneyto","year":"2011","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.biopsych.2013.09.019_bib33","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1176\/appi.ajp.2011.11010052","article-title":"Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: Clinical, protein, and cell type-specific features","volume":"168","author":"Curley","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2013.09.019_bib34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jpsychires.2009.12.007","article-title":"Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia","volume":"44","author":"Duncan","year":"2010","journal-title":"J Psychiatry Res"},{"key":"10.1016\/j.biopsych.2013.09.019_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biopsych.2010.09.036","article-title":"Lack of change in markers of presynaptic terminal abundance alongside subtle reductions in markers of presynaptic terminal plasticity in prefrontal cortex of schizophrenia patients","volume":"69","author":"Fung","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.09.019_bib36","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/npp.2011.102","article-title":"Selective pyramidal cell reduction of GABA(A) receptor alpha1 subunit messenger RNA expression in schizophrenia","volume":"36","author":"Glausier","year":"2011","journal-title":"Neuropsychopharm"},{"key":"10.1016\/j.biopsych.2013.09.019_bib37","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1176\/appi.ajp.2012.12030305","article-title":"Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia","volume":"169","author":"Volk","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2013.09.019_bib38","unstructured":"Hoftman GD, Volk DW, Bazmi HH, Li S, Sampson AR, Lewis DA (in press): Altered cortical expression of GABA-related genes in schizophrenia: Evidence for incomplete developmental trajectories. Schizophr Bull."},{"key":"10.1016\/j.biopsych.2013.09.019_bib39","series-title":"Diagnostic and Statistical Manual of Mental Disorders, 4th ed","year":"1994"},{"key":"10.1016\/j.biopsych.2013.09.019_bib40","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1176\/appi.ajp.2010.10030318","article-title":"Alterations in metabotropic glutamate receptor 1\u03b1 and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia","volume":"167","author":"Volk","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2013.09.019_bib41","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/cercor\/bhr202","article-title":"Cortical opioid markers in schizophrenia and across postnatal development","volume":"22","author":"Volk","year":"2011","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.biopsych.2013.09.019_bib42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1176\/appi.ajp.2007.07081223","article-title":"Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia","volume":"165","author":"Hashimoto","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"34","key":"10.1016\/j.biopsych.2013.09.019_bib43","first-page":"1","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"10.1016\/j.biopsych.2013.09.019_bib44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.schres.2013.02.038","article-title":"Endocannabinoid metabolism in the prefrontal cortex in schizophrenia","volume":"147","author":"Volk","year":"2013","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2013.09.019_bib45","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/cercor\/bhm186","article-title":"Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder","volume":"18","author":"Morris","year":"2008","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.biopsych.2013.09.019_bib46","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.neuropharm.2010.12.029","article-title":"Lamina- and cell-specific alterations in cortical somatostatin receptor 2 mRNA expression in schizophrenia","volume":"62","author":"Beneyto","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2013.09.019_bib47","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/sj.npp.1300710","article-title":"The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: A comparison of haloperidol and olanzapine in macaque monkeys","volume":"30","author":"Dorph-Petersen","year":"2005","journal-title":"Neuropsychopharm"},{"key":"10.1016\/j.biopsych.2013.09.019_bib48","doi-asserted-by":"crossref","first-page":"13957","DOI":"10.1523\/JNEUROSCI.4457-08.2008","article-title":"Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia","volume":"28","author":"Behrens","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2013.09.019_bib49","doi-asserted-by":"crossref","first-page":"10061","DOI":"10.1073\/pnas.90.21.10061","article-title":"Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6","volume":"90","author":"Campbell","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2013.09.019_bib50","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1073\/pnas.94.4.1500","article-title":"Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain","volume":"94","author":"Heyser","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2013.09.019_bib51","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/jnr.10635","article-title":"Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6","volume":"73","author":"Samland","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.biopsych.2013.09.019_bib52","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/glia.22461","article-title":"Astroglial IFITM3 mediates neuronal impairments following neonatal immune challenge in mice","volume":"61","author":"Ibi","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.biopsych.2013.09.019_bib53","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1523\/JNEUROSCI.0099-06.2006","article-title":"The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology","volume":"26","author":"Meyer","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2013.09.019_bib54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1742-2094-9-83","article-title":"Maternal immune activation by poly(I:C) induces expression of cytokines IL-1beta and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain","volume":"9","author":"Arrode-Bruses","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.biopsych.2013.09.019_bib55","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbi.2012.01.015","article-title":"Maternal immune activation by LPS selectively alters specific gene expression profiles of interneuron migration and oxidative stress in the fetus without triggering a fetal immune response","volume":"26","author":"Oskvig","year":"2012","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.biopsych.2013.09.019_bib56","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/S1734-1140(12)70937-4","article-title":"Maternal immune activation leads to age-related behavioral and immunological changes in male rat offspring\u2014the effect of antipsychotic drugs","volume":"64","author":"Basta-Kaim","year":"2012","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.biopsych.2013.09.019_bib57","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbi.2007.09.012","article-title":"Adult brain and behavioral pathological markers of prenatal immune challenge during early\/middle and late fetal development in mice","volume":"22","author":"Meyer","year":"2008","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.biopsych.2013.09.019_bib58","article-title":"Prenatal immune activation induces maturation-dependent alterations in the prefrontal GABAergic transcriptome [published online ahead of print January 17]","author":"Richetto","year":"2013","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2013.09.019_bib59","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbi.2013.01.086","article-title":"Epigenetic changes at gene promoters in response to immune activation in utero","volume":"30","author":"Tang","year":"2013","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.biopsych.2013.09.019_bib60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.schres.2006.11.016","article-title":"Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial","volume":"90","author":"Akhondzadeh","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2013.09.019_bib61","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.schres.2010.04.015","article-title":"Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment","volume":"121","author":"Muller","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2013.09.019_bib62","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-065X.2008.00644.x","article-title":"Therapeutic targeting of Janus kinases","volume":"223","author":"Pesu","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.biopsych.2013.09.019_bib63","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1158\/1078-0432.CCR-12-0653","article-title":"U.S. Food and Drug Administration approval: Ruxolitinib for the treatment of patients with intermediate and high-risk myelofibrosis","volume":"18","author":"Deisseroth","year":"2012","journal-title":"Clin Cancer Res"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322313008603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322313008603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T03:58:44Z","timestamp":1564199924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322313008603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0006322313008603"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2013.09.019","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}